These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17851996)

  • 1. Cost-effectiveness of clinical interventions for AIDS wasting.
    Beaston-Blaakman A; Shepard DS; Stone N; Shevitz AH
    AIDS Care; 2007 Sep; 19(8):996-1001. PubMed ID: 17851996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting.
    Shevitz AH; Wilson IB; McDermott AY; Spiegelman D; Skinner SC; Antonsson K; Layne JE; Beaston-Blaakman A; Shepard DS; Gorbach SL
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):399-406. PubMed ID: 15764956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
    Sendi P; Günthard HF; Simcock M; Ledergerber B; Schüpbach J; Battegay M;
    PLoS One; 2007 Jan; 2(1):e173. PubMed ID: 17245449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental cost-effectiveness of a collaborative care intervention for panic disorder.
    Katon W; Russo J; Sherbourne C; Stein MB; Craske M; Fan MY; Roy-Byrne P
    Psychol Med; 2006 Mar; 36(3):353-63. PubMed ID: 16403243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
    Marshall DA; Strauss ME; Pericak D; Buitendyk M; Codding C; Torrance GW
    Am J Manag Care; 2006 Apr; 12(4):205-14. PubMed ID: 16610922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When does quality-adjusting life-years matter in cost-effectiveness analysis?
    Chapman RH; Berger M; Weinstein MC; Weeks JC; Goldie S; Neumann PJ
    Health Econ; 2004 May; 13(5):429-36. PubMed ID: 15127423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of interventions for depressed Latinos.
    Schoenbaum M; Miranda J; Sherbourne C; Duan N; Wells K
    J Ment Health Policy Econ; 2004 Jun; 7(2):69-76. PubMed ID: 15208467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.
    Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB
    J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.
    Goodman CA; Mutemi WM; Baya EK; Willetts A; Marsh V
    Health Policy Plan; 2006 Jul; 21(4):275-88. PubMed ID: 16682433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of HIV medication adherence support interventions: results of a cross-site evaluation.
    Schackman BR; Finkelstein R; Neukermans CP; Lewis L; Eldred L;
    AIDS Care; 2005 Nov; 17(8):927-37. PubMed ID: 16265786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
    Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
    Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.
    Sinanovic E; Floyd K; Dudley L; Azevedo V; Grant R; Maher D
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S56-62. PubMed ID: 12971655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.